TipRanks
Cigna Corp (CI)
NYSE:CI
US Market
CI
Cigna
RESEARCH TOOLSreports
Want to see CI full AI Analyst Report?

Cigna (CI) Stock Forecast & Price Target

3,677 Followers
See the Price Targets and Ratings of:

CI Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
13 Buy
6 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Cigna
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$338.89
▲(21.33% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $338.89 with a high forecast of $387.00 and a low forecast of $290.00. The average price target represents a 21.33% change from the last price of $279.32.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"237":"$237","388":"$388","274.75":"$274.8","312.5":"$312.5","350.25":"$350.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":387,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$387.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":338.88888888888886,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$338.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":290,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$290.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[237,274.75,312.5,350.25,388],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,267.96,277.11692307692306,286.27384615384614,295.4307692307692,304.5876923076923,313.7446153846154,322.90153846153845,332.05846153846153,341.2153846153846,350.3723076923077,359.52923076923076,368.68615384615384,377.8430769230769,{"y":387,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,267.96,273.4160683760684,278.8721367521367,284.3282051282051,289.7842735042735,295.2403418803419,300.6964102564102,306.1524786324786,311.60854700854696,317.06461538461537,322.5206837606837,327.9767521367521,333.4328205128205,{"y":338.88888888888886,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,267.96,269.6553846153846,271.35076923076923,273.04615384615386,274.7415384615384,276.43692307692305,278.1323076923077,279.8276923076923,281.5230769230769,283.21846153846155,284.9138461538462,286.60923076923075,288.3046153846154,{"y":290,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":285.186,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":238.993,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.507,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270.642,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.013,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":286.001,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.312,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":279.716,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.104,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.54,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":277.509,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.497,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.96,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$387.00Average Price Target$338.89Lowest Price Target$290.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on CI
Jessica Tassan
Piper Sandler
Piper Sandler
$370
Buy
32.46%
Upside
Reiterated
10/23/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Merck & Company (NYSE: MRK) and US Physical Therapy (NYSE: USPH)
RBC Capital Analyst forecast on CI
Ben Hendrix
RBC Capital
RBC Capital
$337
Buy
20.65%
Upside
Reiterated
10/07/26
RBC Capital Remains a Buy on Cigna (CI)
Bernstein Analyst forecast on CI
Lance Wilkes
Bernstein
Bernstein
$381→$387
Buy
38.55%
Upside
Reiterated
10/05/26
Bernstein Sticks to Their Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CI
David S Macdonald
Truist Financial
Truist Financial
$350
Buy
25.30%
Upside
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)
Leerink Partners Analyst forecast on CI
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$300
Hold
7.40%
Upside
Reiterated
10/01/26
Cigna (CI) Gets a Hold from Leerink Partners
Oppenheimer Analyst forecast on CI
Michael Wiederhorn
Oppenheimer
Oppenheimer
$365
Buy
30.67%
Upside
Reiterated
10/01/26
Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)
Evercore ISI Analyst forecast on CI
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$290
Hold
3.82%
Upside
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)
Bank of America Securities Analyst forecast on CI
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$378
Buy
35.33%
Upside
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)
Barclays Analyst forecast on CI
Andrew Mok CFA
Barclays
Barclays
$310
Hold
10.98%
Upside
Reiterated
10/01/26
Barclays Sticks to Its Hold Rating for Cigna (CI)
TD Cowen Analyst forecast on CI
Charles Rhyee
TD Cowen
TD Cowen
$338
Buy
21.01%
Upside
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top NA Picks
Wells Fargo Analyst forecast on CI
Stephen Baxter
Wells Fargo
Wells Fargo
$307
Hold
9.91%
Upside
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)
Morgan Stanley Analyst forecast on CI
Erin Wright
Morgan Stanley
Morgan Stanley
$361
Buy
29.24%
Upside
Reiterated
09/29/26
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Jefferies Analyst forecast on CI
David Windley
Jefferies
Jefferies
$336→$307
Hold
9.91%
Upside
Downgraded
08/03/26
Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies
Raymond James Analyst forecast on CI
Parker Snure
Raymond James
Raymond James
$350→$320
Buy
14.56%
Upside
Reiterated
08/03/26
Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James
Goldman Sachs Analyst forecast on CI
Scott Fidel
Goldman Sachs
Goldman Sachs
$340→$352
Buy
26.02%
Upside
Reiterated
08/02/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on CI
Jessica Tassan
Piper Sandler
Piper Sandler
$370
Buy
32.46%
Upside
Reiterated
10/23/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Merck & Company (NYSE: MRK) and US Physical Therapy (NYSE: USPH)
RBC Capital Analyst forecast on CI
Ben Hendrix
RBC Capital
RBC Capital
$337
Buy
20.65%
Upside
Reiterated
10/07/26
RBC Capital Remains a Buy on Cigna (CI)
Bernstein Analyst forecast on CI
Lance Wilkes
Bernstein
Bernstein
$381→$387
Buy
38.55%
Upside
Reiterated
10/05/26
Bernstein Sticks to Their Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CI
David S Macdonald
Truist Financial
Truist Financial
$350
Buy
25.30%
Upside
Reiterated
10/02/26
Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)
Leerink Partners Analyst forecast on CI
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
$300
Hold
7.40%
Upside
Reiterated
10/01/26
Cigna (CI) Gets a Hold from Leerink Partners
Oppenheimer Analyst forecast on CI
Michael Wiederhorn
Oppenheimer
Oppenheimer
$365
Buy
30.67%
Upside
Reiterated
10/01/26
Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)
Evercore ISI Analyst forecast on CI
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$290
Hold
3.82%
Upside
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)
Bank of America Securities Analyst forecast on CI
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$378
Buy
35.33%
Upside
Reiterated
10/01/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)
Barclays Analyst forecast on CI
Andrew Mok CFA
Barclays
Barclays
$310
Hold
10.98%
Upside
Reiterated
10/01/26
Barclays Sticks to Its Hold Rating for Cigna (CI)
TD Cowen Analyst forecast on CI
Charles Rhyee
TD Cowen
TD Cowen
$338
Buy
21.01%
Upside
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top NA Picks
Wells Fargo Analyst forecast on CI
Stephen Baxter
Wells Fargo
Wells Fargo
$307
Hold
9.91%
Upside
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)
Morgan Stanley Analyst forecast on CI
Erin Wright
Morgan Stanley
Morgan Stanley
$361
Buy
29.24%
Upside
Reiterated
09/29/26
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Jefferies Analyst forecast on CI
David Windley
Jefferies
Jefferies
$336→$307
Hold
9.91%
Upside
Downgraded
08/03/26
Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies
Raymond James Analyst forecast on CI
Parker Snure
Raymond James
Raymond James
$350→$320
Buy
14.56%
Upside
Reiterated
08/03/26
Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James
Goldman Sachs Analyst forecast on CI
Scott Fidel
Goldman Sachs
Goldman Sachs
$340→$352
Buy
26.02%
Upside
Reiterated
08/02/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KURAKura Oncology
LFMDLifeMD
ACHVAchieve Life Sciences
ZYMEZymeworks
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months
Ann HynesMizuho Securities
Success Rate
17/27 ratings generated profit
63%
Average Return
+4.54%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +4.54% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
25/32 ratings generated profit
78%
Average Return
+17.73%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +17.73% per trade.
2 Years
Scott FidelGoldman Sachs
Success Rate
30/32 ratings generated profit
94%
Average Return
+25.19%
Copying Scott Fidel's trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +25.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
25
30
21
24
18
Hold
4
7
5
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
37
26
31
25
In the current month, CI has received 18 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 338.89.
Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.52 with a range of $7.42 to $7.80. The previous quarter’s EPS was $7.78. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.
Next quarter’s earnings estimate for CI is $7.52 with a range of $7.42 to $7.80. The previous quarter’s EPS was $7.78. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $72.64B with a range of $70.51B to $74.28B. The previous quarter’s sales results were $71.60B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.
Next quarter’s sales forecast for CI is $72.64B with a range of $70.51B to $74.28B. The previous quarter’s sales results were $71.60B. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna Corp’s 12-month average price target is 338.89.
    What is CI’s upside potential, based on the analysts’ average price target?
    Cigna Corp has 21.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CI a Buy, Sell or Hold?
          Cigna Corp has a consensus rating of Moderate Buy which is based on 13 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Cigna Corp’s price target?
            The average price target for Cigna Corp is 338.89. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $387.00 ,the lowest forecast is $290.00. The average price target represents 21.33% Increase from the current price of $279.32.
              What do analysts say about Cigna Corp?
              Cigna Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of CI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.